CA057-003

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

Near Add Your Location

Sorting 11 by

Memorial Sloan Kettering Cancer Center
New York, NY
Fully Open
  • Accepting patients
  • Show Principal Investigator
University of Alabama at Birmingham
O'Neal Comprehensive Cancer Center
Birmingham, AL
  • Accepting patients
  • Show Principal Investigator
John Theurer Cancer Center at Hackensack University Medical Center 
Hackensack Meridian Health
Hackensack, NJ
  • Accepting patients
  • Show Principal Investigator
Dana-Farber Cancer Institute
Boston, MA
  • Accepting patients
  • Show Principal Investigator
Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Medicine
Baltimore, MD
  • Accepting patients
  • Show Principal Investigator
Memorial Sloan Kettering Basking Ridge
Basking Ridge, NJ
Limited Activities
  • Accepting patients
  • Show Principal Investigator
Memorial Sloan Kettering Bergen
Montvale, NJ
Limited Activities
  • Accepting patients
  • Show Principal Investigator
Memorial Sloan Kettering Monmouth
Middletown, NJ
Limited Activities
  • Accepting patients
  • Show Principal Investigator
Memorial Sloan Kettering Commack
Commack, NY
Limited Activities
  • Accepting patients
  • Show Principal Investigator
Memorial Sloan Kettering Nassau
Uniondale, NY
Limited Activities
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.